[Federal Register Volume 79, Number 157 (Thursday, August 14, 2014)]
[Notices]
[Pages 47640-47641]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-19245]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-14-14ARR]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden, invites the general
public and other Federal agencies to take this opportunity to comment
on proposed and/or continuing information collections, as required by
the Paperwork Reduction Act of 1995. To request more information on the
below proposed project or to obtain a copy of the information
collection plan and instruments, call 404-639-7570 or send comments to
Leroy Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send
an email to [email protected].
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
Drug Overdose Response Investigation (DORI) Data Collections--New--
National Center for Injury Prevention and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
State and local health authorities frequently call upon CDC's
National Center for Injury Prevention and Control (NCIPC) to assist in
their response to urgent public health problems resulting from drug
use, misuse, abuse, and overdose. When called, NCIPC supports the
states and local health authorities by conducting Drug Overdose
Response Investigations (DORI), which entails a rapid and flexible
epidemiological response. Urgent requests such as DORIs depend on the
time and resources available, number of persons involved, and other
circumstances unique to the urgent conditions at hand and usually
involve the development of procedures, specific data collection
instruments, and the collection of critical data.
This request is for a new generic approval to conduct information
collections during DORIs. A three-year clearance is requested to
ensure: (1) Rapid deployment data collection tools and (2) timely
information collection of vital information. Of particular interest is
response to increasing trends in, or changing characteristics of,
overdose from prescription drugs (with a special interest in opioid
analgesics such as oxycodone or methadone; benzodiazepines such as
alprazolam) and/or illicit drugs (e.g., heroin).
Specifically, this request covers investigative collections with
the
[[Page 47641]]
following aims: (1) To understand sudden increases in drug use and
misuse associated with fatal and nonfatal overdoses; (2) to understand
the drivers and risk factors associated with those trends; and (3) to
identify the groups most affected. This will allow CDC to effectively
advise states on recommended actions to control local epidemics. Thus,
the ultimate goals of these collections are to minimize adverse health
consequences, provide epidemiological data collection support to the
states and, based on the findings from the investigation, appropriately
assist with implementation of prevention and control measures.
Data are collected by epidemiologists, psychologists, medical
professionals, subject matter experts, and biostatisticians. Examples
of data collection modes that may be employed during DORIs include:
Archival record abstractions and reviews, face-to-face interviews,
telephone interviews, web-based questionnaires, and self-administered
questionnaires.
For example, information collected through archival chart review
from hospitals and medical examiners could include demographics, drug
use history, reported medical and mental health conditions, place of
overdose, place of death, drug paraphernalia on the scene, mode of
administration, observers present, naloxone administration, hospital
admittance, autopsy findings, toxicology results, and so forth.
Information collected through interviews with representatives from
agencies involved in preventing, intervening, or responding to drug
overdose could include professional history, personal experience with
drug overdose cases or investigations, prevention or intervention
efforts engaged in, perceptions of characteristics of or changes in
drug overdose cases (e.g., transition from opioids to heroin;
increasing or decreasing rates), and so forth. Collection of
information from nonfatal overdose victims, and friends and family of
overdose victims could include substance use history, prescription drug
history, number of providers and pharmacies used, pain history, co-
occurring health conditions (e.g., abnormal snoring indicative of
respiratory depression), mental health conditions (e.g., depression,
anxiety disorders), enrollment in drug treatment program, sources of
drugs, route of drug administration, criminal history, and so forth.
Finally, collection of spatial information could be obtained through
city, county, and state government agencies to determine structural and
environmental factors associated with location of overdose deaths.
Respondent type will also vary by investigation, but will include
organizations typically involved in prevention, intervention, and
response to drug overdose (e.g., public health, law enforcement
authorities, health systems, and community organizations. Respondents
also may include victims of non-fatal drug overdoses, as well as family
and friends of victims.
During a DORI, data are collected once, with the rare need for
follow-up. There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Drug Overdose Response Investigation Drug Overdose Response Investigation 2,700 1 .5 1,350
Participants. Data Collection Instruments.
---------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 1,350
--------------------------------------------------------------------------------------------------------------------------------------------------------
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-19245 Filed 8-13-14; 8:45 am]
BILLING CODE 4163-18-P